AVALO THERAPEUTICS, INC. (AVTX)

SEC filing

AVALO THERAPEUTICS, INC.

AVTX · CIK 1534120

4 · Sep 1, 2026 · Chief Medical Officer Doyle Mittie sold 679 shares at $20.00/share ($13,580); exercised options for 1,358 shares

Chief Medical Officer Doyle Mittie sold 679 shares at $20.00/share ($13,580); exercised options for 1,358 shares

xslF345X06/form4-09012026_080946.xml

xslF345X06/form4-09012026_080946.xmlSEC.gov

Graphics and non-inline formats (not embedded below).